Union Sues J&J Over Off-Label Uses Of Risperdal
Pharmaceutical company Johnson & Johnson has been slapped with another lawsuit over its popular anti-psychotic Risperdal, this one alleging that the company attempted to market the drug for nonapproved uses....To view the full article, register now.
Already a subscriber? Click here to view full article